English Polski
Vol 29, No 1 (2023)
Research paper
Published online: 2023-06-27

open access

Page views 1426
Article views/downloads 256
Get Citation

Connect on Social Media

Connect on Social Media

Safety and efficacy of venous mechano-chemical ablation of the great saphenous vein

Ahmed A. Shaker1, Ahmed Maged Farghaly1, Ahmed Mohsen Hafez1, Mohamed Fawzy Khattab1, Marwan Yousry1
Acta Angiologica 2023;29(1):10-14.

Abstract

Introduction: Endovenous mechano-chemical ablation of the incompetent great saphenous vein (MOCA) is a new technique that combines mechanical endothelial injury and infusion of a sclerosant agent.

Material and methods: This is a prospective study was conducted on 40 patients who presented with the chronic venous disease at Kasr Al Ainy outpatient vascular surgery clinic with CEAP classification namely C2-C6.

Results: A total of 40 patients were presented with great saphenous vein incompetency, the mean age was (30), 23 patients were male and 17 were female. The vein occlusion rate at one month was 93 percent and at six months was 87 percent respectively.

Conclusions: Endovenous mechanochemical ablation is a safe and effective method for the management of incompetent great saphenous veins compared to open surgery.

Article available in PDF format

View PDF Download PDF file

References

  1. Elias S, Raines JK. Mechanochemical tumescentless endovenous ablation: final results of the initial clinical trial. Phlebology. 2012; 27(2): 67–72.
  2. Proebstle TM, Vago B, Alm J, et al. Treatment of the incompetent great saphenous vein by endovenous radiofrequency powered segmental thermal ablation: first clinical experience. J Vasc Surg. 2008; 47(1): 151–156.
  3. Bos R, Arends L, Kockaert M, et al. Endovenous therapies of lower extremity varicosities: A meta-analysis. J Vasc Surg . 2009; 49(1): 230–239.
  4. Boersma D, van Eekeren RR, Werson DAB, et al. Mechanochemical endovenous ablation of small saphenous vein insufficiency using the ClariVein(®) device: one-year results of a prospective series. Eur J Vasc Endovasc Surg. 2013; 45(3): 299–303.
  5. Lane T, Bootun R, Dharmarajah B, et al. A multi-centre randomised controlled trial comparing radiofrequency and mechanical occlusion chemically assisted ablation of varicose veins - Final results of the Venefit versus Clarivein for varicose veins trial. Phlebology. 2017; 32(2): 89–98.
  6. Rybak Z, Janeczek M, Dobrzynski M, et al. Study of Flebogrif-A New Tool for Mechanical Sclerotherapy-Effectiveness Assessment Based on Animal Model. Nanomaterials (Basel). 2021; 11(2).
  7. Tomasz Zubilewicz., (2016) “Application of Endovenous Mechanochemical Ablation (MOCA) with Flebogrif TM to Treat Varicose Veins of the Lower Extremities: A Single Center Experience over 3 Months of Observation,” Acta Angiologica.
  8. Ciostek P, Kowalski M, Woźniak W, et al. Phlebogriffe – a new device for mechanochemical ablation of incompetent saphenous veins: a pilot study. Phlebological Review. 2015; 3: 72–77.
  9. Rutherford RB. (2014) Chronic venous disorders: non operative treatment. In: Rutherford RB, editor. Vascular surgery. 8th ed. Philadelphia: WB Saunders;. p. 858–67.
  10. Alozai T, Huizing E, Schreve M, et al. A systematic review and meta-analysis of mechanochemical endovenous ablation using Flebogrif for varicose veins. J Vasc Surg Venous Lymphat Disord. 2022; 10(1): 248–257.e2.